Breaking News Instant updates and real-time market news.

ACST

Acasti Pharma

$2.14

0.03 (1.42%)

04:55
10/11/19
10/11
04:55
10/11/19
04:55

Acasti Pharma management to meet with Oppenheimer

Meeting to be held in San Francisco on October 10-11 hosted by Oppenheimer.

  • 11

    Oct

  • 23

    Oct

  • 24

    Oct

ACST Acasti Pharma
$2.14

0.03 (1.42%)

07/09/19
AGIS
07/09/19
INITIATION
Target $3
AGIS
Buy
Aegis starts 'promising Omega-3 story' Acasti with Buy rating, $3 price target
As previously reported, Aegis analyst Nathan Weinstein initiated Acasti Pharma (ACST) with a Buy rating and $3 price target, telling investors that the company's Omega-3 therapeutic for the treatment of very high triglycerides, called CaPre, has demonstrated "interesting efficacy" in phase 2 study. Several companies have entered or could be close to entering the prescription Omega-3 space, including Amarin (AMRN), but Weinstein points to precedent cases of third and later entrants achieving market success in various therapeutic categories.
07/18/19
OPCO
07/18/19
INITIATION
Target $7
OPCO
Outperform
Acasti Pharma initiated with an Outperform at Oppenheimer
Oppenheimer analyst Leland Gershell started Acasti Pharma with an Outperform rating and $7 price target.
07/18/19
07/18/19
INITIATION
Target $7

Outperform
Oppenheimer bullish on Acasti Pharma, initiates with an Outperform
As previously reported, Oppenheimer analyst Leland Gershell started coverage of Acasti Pharma (ACST) with an Outperform rating and $7 price target. While the analyst notes that Vascepa's prospects to serve a multibillion-dollar sales opportunity have driven significant value appreciation for Amarin (AMRN), he believes Acasti Pharma's potentially best-in-class omega-3 is only months away from pivotal readouts in the very high triglycerides niche, and anticipates a REDUCE-IT-like label expansion can be secured without new outcomes data. With shares trading at just a about $100M EV, Gershell believes Acasti holds "considerable upside" as CaPre approaches commercialization, its advantages are better appreciated, and Vascepa's sales growth continues to impress.
08/29/19
RILY
08/29/19
INITIATION
Target $7.75
RILY
Buy
Acasti Pharma initiated with a Buy at B. Riley FBR
B. Riley FBR analyst George Zavoico earlier today initiated coverage of Acasti Pharma with a Buy rating and $7.75 price target. The stock in early trading is up 7% to $1.83. The analyst expects positive Phase III results in early Q1 of 2020 for the company's leading drug candidate, CaPre. CaPre is indicated for adverse cardiovascular event risk reduction in patients with elevated levels of certain lipids, a big market of ~80M Americans, Zavoico tells investors in a research note. He believes CaPre could be the best-in-class omega-3 fatty acid drug and could capture a large share of the market. He also expects a capital raise by Acasti or partnership agreement later this year or early in 2020.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
10/18/19
10/18
14:17
10/18/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
10/18/19
10/18
14:16
10/18/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$82.71

-1.42 (-1.69%)

14:15
10/18/19
10/18
14:15
10/18/19
14:15
Options
Diamondback Energy put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

QQQ

Invesco QQQ Trust

$192.00

-1.56 (-0.81%)

, SPY

SPDR S&P 500 ETF Trust

$298.50

-0.74 (-0.25%)

14:13
10/18/19
10/18
14:13
10/18/19
14:13
Technical Analysis
On The Fly: ETF fund flow highlights »

For the week creations…

QQQ

Invesco QQQ Trust

$192.00

-1.56 (-0.81%)

SPY

SPDR S&P 500 ETF Trust

$298.50

-0.74 (-0.25%)

IWM

iShares Trust Russell 2000 Index Fund

$152.78

-0.56 (-0.37%)

XLU

Utilities SPDR

$63.76

0.16 (0.25%)

IVV

iShares Core S&P 500

$300.17

-0.76 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XEC

Cimarex Energy

$42.31

-0.36 (-0.84%)

14:05
10/18/19
10/18
14:05
10/18/19
14:05
Options
Cimarex Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

SPXC

SPX Corporation

$40.48

0.265 (0.66%)

13:58
10/18/19
10/18
13:58
10/18/19
13:58
Initiation
SPX Corporation initiated  »

SPX Corporation initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

WE

We Company

$0.00

(0.00%)

, JPM

JPMorgan

$120.80

0.41 (0.34%)

13:58
10/18/19
10/18
13:58
10/18/19
13:58
Periodicals
SoftBank, JPMorgan submit competing rescue packages for WeWork, FT says »

SoftBank (SFTBF) and…

WE

We Company

$0.00

(0.00%)

JPM

JPMorgan

$120.80

0.41 (0.34%)

SFTBF

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 27

    Oct

  • 04

    Nov

  • 21

    Nov

  • 14

    Jan

13:55
10/18/19
10/18
13:55
10/18/19
13:55
General news
Action Economics Survey results: »

Action Economics Survey…

JNJ

Johnson & Johnson

$129.11

-7.09 (-5.21%)

13:48
10/18/19
10/18
13:48
10/18/19
13:48
Recommendations
Johnson & Johnson analyst commentary  »

Credit Suisse says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 07

    Dec

DIS

Disney

$131.17

-1.2 (-0.91%)

, SNE

Sony

$58.86

-1.195 (-1.99%)

13:47
10/18/19
10/18
13:47
10/18/19
13:47
On The Fly
Box Office Battle: 'Maleficent,' 'Zombieland' sequels hit theaters »

Welcome to "Box Office…

DIS

Disney

$131.17

-1.2 (-0.91%)

SNE

Sony

$58.86

-1.195 (-1.99%)

T

AT&T

$38.09

0.27 (0.71%)

VIA

Viacom

$25.00

-0.6 (-2.34%)

VIAB

Viacom

$22.24

-0.37 (-1.64%)

CMCSA

Comcast

$45.49

-0.45 (-0.98%)

CMCSK

Comcast

$0.00

(0.00%)

LGF.A

Lionsgate

$8.50

-0.1 (-1.16%)

LGF.B

Lionsgate

$8.00

-0.07 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 14

    Nov

  • 14

    Nov

  • 18

    Nov

  • 19

    Nov

MAS

Masco

$43.82

0.18 (0.41%)

13:45
10/18/19
10/18
13:45
10/18/19
13:45
Options
Masco call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

IGT

International Game

$13.15

-0.25 (-1.87%)

13:25
10/18/19
10/18
13:25
10/18/19
13:25
Options
International Game call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
10/18/19
10/18
13:25
10/18/19
13:25
General news
Wall Street is taking a hit on a couple of news items »

Wall Street is taking a…

13:25
10/18/19
10/18
13:25
10/18/19
13:25
Conference/Events
JPMorgan autos/auto parts analyst to hold an analyst/industry conference call »

Autos & Auto Parts…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
10/18/19
10/18
13:17
10/18/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
10/18/19
10/18
13:16
10/18/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GGAL

Grupo Financiero

$12.45

-0.05 (-0.40%)

13:15
10/18/19
10/18
13:15
10/18/19
13:15
Options
Grupo Financiero put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWBO

Northwest Biotherapeutics

$0.00

(0.00%)

13:12
10/18/19
10/18
13:12
10/18/19
13:12
Syndicate
Breaking Syndicate news story on Northwest Biotherapeutics »

Northwest Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BA

Boeing

$355.77

-13.36 (-3.62%)

13:12
10/18/19
10/18
13:12
10/18/19
13:12
Periodicals
Boeing pilot said he 'lied' to FAA in texts to colleague, NY Times reports »

Mark Forkner, a Boeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

MAT

Mattel

$11.18

0.07 (0.63%)

13:06
10/18/19
10/18
13:06
10/18/19
13:06
Recommendations
Mattel analyst commentary  »

Jefferies sees increased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

13:05
10/18/19
10/18
13:05
10/18/19
13:05
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 10/18…

FEYE

FireEye

$15.06

-0.06 (-0.40%)

13:05
10/18/19
10/18
13:05
10/18/19
13:05
Options
FireEye call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

BHGE

Baker Hughes

$0.00

(0.00%)

13:03
10/18/19
10/18
13:03
10/18/19
13:03
Hot Stocks
Baker Hughes reports U.S. rig count down 5 to 851 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

MAT

Mattel

$11.26

0.15 (1.35%)

12:59
10/18/19
10/18
12:59
10/18/19
12:59
Periodicals
Study finds Fisher-Price Rock 'n Play 'dangerous and deadly,' CBS News says »

A study has found that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

NKE

Nike

$95.67

0.13 (0.14%)

12:55
10/18/19
10/18
12:55
10/18/19
12:55
Options
Nike put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.